SAMLYN CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CRVS)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
SAMLYN CAPITAL, LLC
Security
Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
CRVS
Shares outstanding
67,765,583 shares
Disclosed Ownership
4,065,935 shares
Ownership
6%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:34:17 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SAMLYN CAPITAL, LLC 6% 4,065,935 0 4,065,935 By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member*
SAMLYN, LP 6% 4,065,935 0 4,065,935 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member*
ROBERT POHLY 6% 4,065,935 0 4,065,935 /s/ Robert Pohly Robert Pohly*